Search This Blog

Friday, October 28, 2022

Biogen Alzheimer's drug linked to patient death

 

Biogen (NASDAQ:BIIB) shares dropped in the pre-market trading Friday after Stat News reported that the investigational Alzheimer's therapy
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)